Brief: Strides Pharma Science Receives USFDA Approval For Acetaminophen And Ibuprofen Tablets
20/01/2025 11:05
Jan 20 (Reuters) - Strides Pharma Science Ltd SRID.NS :
* STRIDES PHARMA SCIENCE LTD - RECEIVES USFDA APPROVAL FOR
ACETAMINOPHEN AND IBUPROFEN TABLETS
* STRIDES PHARMA SCIENCE LTD - APPROVAL WILL ENHANCE
STRIDES' OTC
PRODUCT PORTFOLIO
Source text: ID:nBSEbPMJqh
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees